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SYNOPSIS 
The protein mammalian target of rapamycin (mTOR) is a serine/threonine kinase 
regulating a number of biochemical pathways controlling cell growth. mTOR exists in two 
complexes termed mTORC1 and mTORC2. Raptor is associated with mTORC1 and is 
essential for its function. Ablation of Raptor in skeletal muscle results in several 
phenotypic changes including decreased life expectancy, increased glycogen deposits and 
alterations of the twitch kinetics of slow fibres. Here we show that in muscle specific raptor 
knock-out the bulk of glycogen phosphorylase is mainly associated in its cAMP-non 
stimulated form with sarcoplasmic reticulum membranes. In addition, 3[H]-ryanodine and 
3[H]-PN200-110 equilibrium binding show a ryanodine to dihydropyridine receptors  ratio 
of 0.79 and 1.35 for wild type and raptor knock-out skeletal muscle membranes, 
respectively.  Peak amplitude and time to peak of the global calcium transients evoked by 
supramaximal field stimulation were not different between wild type and raptor knock-out. 
However, the increase of the voltage sensor-uncoupled RyRs leads to an increase of both 
frequency and mass of elementary calcium release events (ECRE) induced by hyper-
osmotic shock in FDB fibres from raptor knock-out. This study shows that the protein 
composition and function of the molecular machinery involved in skeletal muscle 
excitation-contraction coupling is affected by mTORC1 signaling. 
 
SUMMARY STATEMENT (40 words) 
A mammalian target of rapamycin (mTOR) is a complex regulating cell growth, 
proliferation and autophagy. Here show that mTOR complex1 also affects the expression of 
dihydropyridine receptor, a key component of the supramolecular complex responsible for 
skeletal muscle excitation-contraction coupling. 
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INTRODUCTION 
The mammalian Target of Rapamycin (mTOR) is a serine/threonine kinase 
controlling different biochemical pathways activated in response to growth factor and 
nutrient availability, including protein synthesis, ribosome biogenesis, nutrient transport, 
lipid synthesis and autophagy, thus playing a central role in metabolism, growth and aging 
[1-5]. Two different mTOR complexes possessing different roles within the cell have been 
identified: mTORC1 and mTORC2. The immunosuppressant drug rapamycin is an allosteric 
inhibitor of mTORC1, a complex playing a role in nutrient sensing and controlling protein 
synthesis, lipid synthesis and glycolysis [6]. After forming a complex with its cytoplasmic 
receptor FKBP12 (FK506 binding protein), rapamycin binds mTORC1 and induces its 
destabilization, resulting in the inability of mTOR to phosphorylate target proteins [6]. 
mTORC1 complex is made up by mTOR, regulatory associated protein of mTOR (raptor), 
mammalian LST8/G-protein β-subunit like protein (mLST8/GβL) and PRAS40 [7,8] Its 
kinase activity is regulated through a dynamic interaction between mTOR and raptor, the 
latter being a conserved 150-kDa protein, which besides mTOR, also interacts with S6K1 
and 4E-BP1. mTORC2 on the other hand, is largely insensitive to rapamycin, is active in 
growing cells and regulates the actin cytoskeleton, cell survival and apoptosis. It forms a 
complex with rictor, mSIN1, mLST8 and mTOR [9]. 
During the past decade, research on the role of mTOR has revealed that this kinase is 
implicated in a variety of diseases, including cancer, neurodegeneration and metabolic 
disorders [9]. Furthermore mTOR activity has been shown to be involved in the control of 
muscle mass and indeed rapamycin treatment delays recovery of skeletal muscle from 
atrophy while activation of the mTOR’s upstream components induces muscle hypertorphy 
[10].  It has been shown that skeletal muscle specific mTOR inactivation increases the 
glycogen content of muscle fibres, an effect linked to the down-regulation of glycogen 
phosphorylase and of other enzymes involved in the glycogenolytic pathway [11]. Similar 
results were also obtained by Bentzinger et al. who investigated the role of the mTORC1 
signalling pathway in skeletal muscle, by generating muscle specific raptor KO mice 
(RamKO)[12]. Skeletal muscles of RamKO mice became progressively atrophic, had 
increased glycogen content and showed a transition of the metabolic signature from 
oxidative to glycolitic, despite slow twitch fibre type predominance [12]. Although RamKO 
mice have  poor  in vivo oxidative muscle performance on the running wheel, in vitro tetanic 
stimulation shows that isolated EDL and soleus from RamKO mice are more resistent to 
fatigue. The reduction of absolute force development is accounted for by the decrease of 
muscle mass since after normalisation for cross sectional area there is no significant 
difference of maximal tetanic force between control and RamKO mice.  Nevertheless the 
twitch kinetics of the soleus from RamKO mice are dramatically affected: there is an 
increased time to peak and almost doubling of the half relaxation time. Because of these 
changes and because mTORC1 inhibition is a common therapeutic strategy in humans, we 
investigated in more detail the functional changes of ablation of mTORC1 in skeletal 
muscle by examining excitation-contraction (E-C) coupling in RamKO mice. E-C coupling 
involves the conversion of an electrical signal into a transient increase of the [Ca2+] and is 
initiated by conformational changes at the level of the L-type voltage dependent calcium 
channel (DHPR, Cav1.1) localized in the membrane of the transverse tubules [13,14]. 
Activation of Ca2+ release from terminal cisternae is due to the transmission of a 
conformational change occurring on the DHPR’s, to the ryanodine receptor (RyR1) via 
direct protein-protein interaction [15-17]. The resulting increase in the intracellular [Ca2+] is 
due to the opening of the RyR1 and this is followed by Ca2+ removal which depends mostly 
on the activity of sarcoplasmic reticulum calcium pumps (SERCA) localized in the 
longitudinal sarcoplasmic reticulum, and, to a lesser extent, on the sarcolemmal Na+/Ca2+ 
exchanger and plasmalemma Ca2+ pump [18]. Mutations in the two Ca2+ channels (RyR1 
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and DHPR α1 subunit) directly involved in E-C coupling are the underlying feature of a 
group of several disorders including core myopathies in which the underlying histological 
feature is the presence of cores and fibre type I predominance (for review see [19]). 
Interestingly, the muscles of RamKO mice also exhibit core-like structures and slow fibre 
type predominance [12]. 
In the present study we investigated the functional and biochemical properties of the 
sarcoplasmic reticulum (SR) membranes from RamKO mice. We found that the inactivation 
of mTORC1 is associated with the compartmentalization of glycogen phosphorylase to 
sarcoplasmic reticulum membranes. In addition, we found an increase of the:  i) half-time of 
the decay of the calcium transient in soleus fibres; ii) ryanodine to dihydropyridine receptors 
ratio; iii) frequency and mass of elementary calcium release events (ECRE) induced by 
hyperosmotic shock in FBD fibres.  Altogether our data suggest that protein composition 
and function of the membrane compartments involved excitation-contraction coupling is 
affected by mTORC1 signalling.  
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MATERIALS AND METHODS 
 
RamKO mice: details of the targeting strategy and initial characterization of RamKO mice 
are previously described [12]. Knockout mice were identified by PCR amplification of 
genomic DNA. All experiments were conducted on male mice in accordance with local 
Kantonal guidelines and regulations (Kantonales Veterinäramt Basel Stadt).  
 
RNA extraction, reverse transcription and PCR reactions: Total RNA was extracted 
from mouse leg muscles using Tri-reagent following the manufacturer’s recommendations 
(molecular Research Centre). Total RNA was converted into cDNA using SuperScript(TM) II 
Reverse Transcriptase (Invitrogen) as previously described [20]. PCR reactions were carried 
out using the following primer sets: Mouse β-actin Forward: 5'-
GGACCTGACAGACTACCTCA-3' and Reverse 5’ GCAGTAATCTCCTTCTGCAT-3'; 
DHPRα1 (Cav1.1) Forward 5' –CATTAGGTAGAGCCGTGCACCTG-3’ and Reverse 5’- 
GCCTGTTGTCATGACGAAGTTAGC- 3’. Amplification conditions were 5 min at 95°C 
followed by 35 cycles of 30 s denaturation at 92°C, 40 s annealing at the recommended 
temperature for each primer pair and 40 s extension at 72°C followed by a final extension 
for 5 min at 72°C using the 2.5x Master Mix Taq polymerase from Eppendorf. The products 
of the PCR reaction were separated on a 1% agarose gel, and the DNA bands were 
visualized by ethidium bromide staining. 
 
SR isolation, Western blotting and biochemical assays: Total SR was prepared as 
previously described from mouse skeletal muscle [20]; vesicles enriched in terminal 
cisteranae, longitudinal sarcoplasmic reticulum and plasmalemma were prepared as 
described by Saito et al. [21] and stored in liquid nitrogen until used. C2C12 myotubes were 
treated for 16 hours with 20 µM rapamycin or left untreated; cells were then washed twice 
with PBS, harvested and the heavy SR protein fraction was obtained by differential 
centrifugation. For Western blotting, proteins were separated by SDS PAGE, blotted onto 
nitrocellulose and probed with commercial antibodies against SR proteins (SERCA1, 
SERCA 2, calsequestrin, calreticulin, sarcalumenin, RyR1, DHPRα1, DHPR ß1, albumin, 
SRP-35 or anti-JP-45 antibodies [20] followed by peroxidase conjugated secondary 
antibodies. The immunopositive bands were visualized by chemiluminescence as previously 
described [22]. To accurately quantify DHPR and RyR content in the SR, and the Ca2+ 
dependency of [3H]ryanodine binding, radioligand binding experiments using [3H] PN200-
110 (DHPR expression) and [3H]ryanodine were performed as described [23]. The different 
free Ca2+ concentrations (750 pM, 9.1 nM, 95 nM, 1.1 µM, 9 µM, 104 µM, 1 mM) were 
obtained by the addition of different amounts of CaCl2 as described by Fabiato [24]. The 
amount of bound [3H] ligand was measured by liquid scintillation counting. 
 
In Vitro Muscle Strength Assessment: To test force in vitro, EDL and soleus muscles were 
dissected and mounted into a muscle testing setup (Heidelberg Scientific Instruments). 
Muscles were stimulated with 15-V pulses for 0.5 ms, and force was digitized at 4 kHz by 
using an AD Instruments converter. EDL tetanus was recorded in response to a 400 ms train 
of pulses delivered at 10–120 Hz;  soleus, tetanus was recorded in response to an 1100 ms  
train of pulses delivered at 10–150 Hz . Specific force was normalized to the muscle cross-
sectional area [CSA] per wet weight (mg)/length (mm) per 1.06 (density mg/mm3) as 
previously described [23].  
 
Isolation of Extensor Digitorum Longus (EDL) and soleus muscle fibres: Single muscle 
fibres were obtained from 6-8 weeks old mouse hindlimbs by enzymatic dissociated, as 
previously described [25]. Briefly, muscles were dissected and pinned via the tendons to a 
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Sylgard-lined dissecting chamber. The outer connective tissue was removed, and the 
muscles were incubated in Tyrode’s solution containing 0.22% Type I collagenase (Sigma) 
at 37°C for 1 h followed by rinsing in 10% foetal bovine serum in DMEM. To release single 
fibres, muscles were triturated gently in serum free DMEM, then plated on glass coverslips 
pre- treated for 2 hours with 1.5 µl of natural mouse laminin (Invitrogen) diluted with 
distilled water. Fibres were then incubated in DMEM 10% foetal bovine serum, 1% 
Penicillin/Streptomycin, 5% CO2 at 37°C overnight. FDF fibers were isolated as previously 
described [23].  
 
Calcium measurements: The resting Ca2+ concentration was monitored in isolated fibres 
from RamKO mice and control littermates with the ratiometric fluorescent Ca2+indicator 
indo-1/AM; changes in the [Ca2+]i induced by electrical depolarization were monitored in 
EDL and soleus fibres loaded with Mag-Fluo-4/AM in Tyrode’s buffer. All experiments 
were carried out at room temperature (20-22°C) in the presence of 50 µM N-benzyl-p-
toluensulfonamide (BTS) (Tocris) to minimize movement artefacts.  Measurements were 
carried out with a Nikon ECLIPSE TE2000-U inverted fluorescent microscope equipped 
with a 20x PH1 DL magnification objective. The light signals from a spot of 1 mm diameter 
of the magnified image of FDB fibres, were converted into electrical signals by a 
photomultiplier connected to a Nikon Photometer P101 amplifier. Calcium transients were 
collected by custom made (RCS AUTOLAB) software and analyzed by PowerLab Chart5 
and Origin.6 programs. Changes in fluorescence were calculated as ΔF/F = (Fmax-
Frest)/(Frest). 
FDB fibres were isolated, kept for 4 hr in a 37°C 5% CO2 cell incubator, placed in a laminin 
coated coverslip and loaded for 20 min at room temperature with 10 µM fluo-4 AM Ca2+ 
indicator (fluo-4 AM, Molecular Probes, Eugene, OR, USA). All experiments were 
performed at room temperature.. ECREs were measured using a Nikon A1R laser scanning 
confocal microscope (Nikon Instruments Inc. Melville, USA) with a 60X oil immersion 
Plan Apo VC Nikon objetive, numerical aperture 1.4. (Nikon Instruments Inc. Melville, 
USA). 5 sec duration linescan images (x,t) were acquired in resonant mode at 7680 lps with 
512 pixels (0.05 µm/pixel) in the x- and 39936 pixels (0.126 ms/pixel) in the t-direction 
using a pinhole size of 72.27 µm. Fifteen images were taken at different positions across 
each cell. The Ca2+ indicator was excited with a laser at 487 nm and the fluorescence 
emitted at 525+/-25 nm was recorded. To minimize photo damage, the laser intensity was 
set at 3~4 % of the maximal power. The viability of fibres after osmotic shock was assessed 
by monitoring single calcium transient evoked by supramaximal field stimulation pulses. 
Fibres were first perfused with isotonic (~290 mOsm) Normal Ringer (NR) (in mM, 140 
NaCl; 2 MgCl2; 2.5 CaCl2; 10 HEPES; 5 KCl; pH adjusted to 7.4) using a Minipuls 2 
peristaltic pump (Gilson Medical Electronics, France). To induce ECREs cells were 
perfused with a Hypertonic solution (~420 mOsm) by increasing the Ca2+ concentration to 
50 mM the (in mM, 140 NaCl; 2 MgCl2; 50 CaCl2; 10 HEPES; 5 KCl; pH adjusted to 7.4) 
[26, 27]. Osmolarity of the solution was assessed with a Vogel 801 Osmometer (Vogel 
GmbH, Gießen, Germany). All solution contained 10 µM BTS. 
 
ECRE analysis 
ECREs morphology (amplitude, ΔF/F0; full width at half-maximum amplitude, FWHM, full 
duration at half-maximum amplitude FDHM) were determined from linescan images using 
the open source image analyser software Fiji [28]. After images were binned by average 4x 
at the t axis, they were processed using the automated spark detection plugin Sparkmaster 
[29]. Because of the heterogeneity of the ECREs duration, events were split in two groups: 
the short lasting events with less than 50 ms of FWHM and the long lasting events ECREs 
with >50 ms of FWHM duration [30]. Frequency was calculated for each group by counting 
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the number of events occurring per image. The mass was determined by the following 
formula mass= 1.206* ΔF/F0*FWHM3 [31]. Statistical analysis was performed using the 
program OriginPro® version 8.6.0 (Northampton, MA). ECRE  derived from 25 and 26 
fibres obtained from 5 WT and RamKO mice, respectively. Data is expressed as mean ± 
SEM; values were considered statistically significant if  P<0.05 using the Student’s t-test.  
 
Glycogen phosphorylase activity measurement: Glycogen phosphorylase activity was 
measured as described [32-34]. Reactions were initiated by adding 30-60 µg of SR to a 500 
µl of reaction buffer containing 50 mM imidazole pH 7.0, 20 mM K2HPO4, 1.25 mM 
MgCl2, 5 µM glucose 1,6-diphosphate, 0.5 mM DTT, 3 µg/ml phosphoglucomutase, 0.25% 
BSA, 10 mg/ml AMP-free glycogen. For measurement of total activity (forms “a” and “b”) 
AMP was added to obtain a final concentration of 3 mmol/l. The reaction was carried out at 
30°C for 30 min (total activity), or for 60 min (to determine the mount of form “a”) and 
terminated by the addition of 60 µl 0.5 M HCl. Aliquots of 50 or 100 µl (for total and form 
“a” measurement, respectively) of primary reaction were added to 1 ml of a glucose-6-
phosphate dehydrogenase reaction buffer containing 50 mM Tris-HCl, pH 8.0, 1 mM 
EDTA, 250 µM NADP and 0.5 µg/ml glucose-6-phosphate dehydrogenase. This reaction 
was allowed to proceed for 10 min at room temperature and the absorbance at 340 nm of the 
samples was determined spectrophotometrically to quantify the degree of conversion of 
NADP to NADPH (which is proportional to the content of glucose 6-phosphate formed in 
the first reaction). Glycogen phosphorylase activity is expressed in micromoles per minute 
per milligram protein (U/mg). 
 
Luciferase reporter assay: The constructs containing DHPRα1.1 promoter region 
fragments (Luc7P-724, Luc/P756) were cloned in frame in pGL3-basic expression vector 
(Promega)[35]. C2C12 myoblasts (2x104 cells per dish) were plated on gelatin-coated 35 mm 
cell culture dishes and allowed to grow in DMEM plus Glutamax, 4.5 g/l glucose, 20% 
foetal bovine serum, 50 units/ml penicillin, 50 µg/ml streptomycin until 50% confluent. 
Two µg of each construct and 200 ng of the control vector pRL-TK were used for 
transfection using the FuGENE6 transfection reagent (Roche). Twenty four hours after 
transfection cells were induced to differentiate by changing the medium to DMEM plus 
Glutamax, 4.5 g/l glucose, 5% horse serum and penicillin/streptomycin. After 4-6 days, 
when cells had visibly fused into mytoubes, 20 µM Rapamycin (Sigma) was added as 
described [36, 37]. Cells were then washed twice with PBS and lysed using Passive Lysis 
Buffer (Promega). Firefly Luciferase and Renilla activity were measured with Victor2 
Luminometer (PerkinElmer). Firefly Luciferase activity was normalized to Renilla activity 
and expressed as mean  (± S.E.M) enzymatic activity units. 
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RESULTS  
Mechanical properties of isolated fibres and content of proteins involved in excitation-
contraction coupling in skeletal muscles of RamKO mice 
 Ablation of raptor induces changes of the mechanical properties of fast and slow 
twitch muscles [12]; figure 1 shows representative traces of twitch and tetanic force of EDL 
and soleus from control and RamKO mice [12]. Although tetanic specific force in EDL and 
soleus muscles do not vary between control and RamKO [12] mice, the twitch kinetics in 
RamKO soleus show a remarkable prolongation of the half relaxation time at lower peak 
force.  The changes of the mechanical properties of the twitch  in EDL and soleus muscles 
could be due (i) to fibre-type switching induced by ablation of Raptor, (ii) to an effect on the 
contractile protein machinery, (iii) to alterations of the E-C coupling mechanism, or (iv) to a 
combination of two or more of these mechanisms.  
 
Protein composition of skeletal muscle sarcoplasmic reticulum from RamKO mice 
 Analysis of the main protein components of total sarcoplasmic reticulum membranes 
from RamKO mice and control littermates revealed no significant changes in the content of 
SERCA1, SERCA2, JP-45, calsequestrin and calreticulin. While there was a small but 
significant decrease in sarcalumenin (Fig. 2), a modulator of SERCA activity [38]. We also 
found a decrease of SRP35, a newly identified membrane-bound retinol dehydrogenase of 
sarcotubular membranes [22]. 
 
RamKO ablation affects the excitation-contraction coupling macromolecular complex 
 To study in greater detail the effect of raptor ablation, we determined the membrane 
density of the two core components of the E-C coupling machinery, namely the Cav1.1 
(α1.1 of the DHPR) and RyR1 by performing quantitative Western blot analysis and 
equilibrium ligand binding on the crude microsomal preparation isolated from skeletal 
muscle of RamKO and control littermates. The most interesting results of this study are that 
the content of Cav1.1 in RamKO mice was reduced by almost 50% compared to control 
littermates (Fig. 3A). Equilibrium binding of the Cav1.1 ligand PN200-100 to crude SR 
membranes shows that the Bmax for PN200-100 binding was 0.68±0.05 and 1.25±0-13 
pmoles/mg protein in RamKO and control littermates, respectively, with no significant 
changes of its dissociation constant (Kd = 0.96 ± 0.16 vs.1.35 ± 0.32 nM, mean ± S.E.M., n 
= 6 for RamKO and control littermates, respectively). The reduced expression of Cav1.1 is, 
surprisingly, accompanied by a 3.5 fold increase of the content of the Cavß1 subunit (Fig. 
3B and C).  On the other hand, the decrease in the total amount of Cav1.1 was not due to a 
reduction of the relative amount in T-tubule membranes in the total sarcotubular membrane 
fraction, as the content of albumin, a marker for T-tubules [39] was unchanged (Fig. 3B and 
C and Fig. 4B). mTORC1 regulates protein expression by affecting translation via S6K1 and 
4E-BP [5], and/or by controlling the transcription of several additional genes [40]. To 
determine if the decrease in Cav1.1 in the muscles of RamKO mice was due to alterations in 
transcription we performed semi-quantitative PCR experiments. As shown in Fig. 4A there 
were no significant changes in Cav1.1 mRNA content in RamKO mice. We next evaluated 
the activity of the Cav1.1 promoter in C2C12 myotubes and HEK293 cells  transfected with a 
luciferase reporter construct containing the 5’ flanking region of the Cav1.1 gene. Figure 4C 
shows that the Cav1.1 promoter is active in C2C12 myotubes but not in HEK293 cells. Since 
FKBP12 is a ubiquitously expressed protein, including in C2C12 myotubes [41], we next 
tested the effect of rapamycin, a drug which pharmacologically mimics the effect of 
knocking out raptor, on the activity of the Cav1.1 promoter. Incubation of C2C12 myotubes 
for 2 and 16 hours with 20 µM rapamycin abolished the phosphorylation of the mTORC1 
downstream target S6 ribosomal protein (Fig. 4D), without influencing the activity of the 
Cav1.1 promoter (Fig. 4C). Nevertheless, rapamycin treatment of C2C12 myotubes causes a 
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decrease of the immunoreactive band corresponding to the Cav1.1 (Fig.4E) without effecting 
calreticulin (CR) content, an extrinsic protein of the sarcoplasmic reticulum membrane.  Our 
data clearly show that, even in the presence of a partial inhibition of the mTORC1 complex 
[42], the phenotype of rapamycin treated C2C12 cells recapitulate  the effect of Cav1.1 
expression that observed in RamKO mature skeletal muscle fibres. In particular, it appears 
that functional ablation of mTORC1 affects the synthesis and/or the stability of Cav1.1. A 
great deal of data show that rapamycin dissociats FKBP12 from the RyR complex leading to 
leaky RyRs [43]. It is unlikely that the decrease of the Cav1.1 expression results from the 
acute appearance of leaky RyR in C2C12 cells, since chronic disregulation of intracellular 
calcium concentration in muscle fibres expressing leaky RyR1 mutation do not display a 
decrease of Cav1.1 current density [44]. The decrease of the total sarcotubular membrane 
density of Cav1.1 was apparently also not paralleled by a decrease of the sarcoplasmic 
reticulum RyR1 calcium release channels as we found no change in the Bmax of 
equilibrium [3H]-ryanodine binding to the total SR membrane fraction (0.99 +/0.1 vs 0.92+/-  
pmol/mg pr for WT and RamKO, respectively) (Fig. 5) from RamKO and control 
littermates.  
 
Glycogen phosphorylase is targeted to sarcoplasmic reticulum membrane in skeletal 
muscle from RamKO mice 
 Skeletal muscles from RamKO and control littermates were homogenized and 
fractionated by differential centrifugation. Comparison of the protein profile of total 
homogenates, shows a decrease of a band of 97 kDa in the total homogenate of skeletal 
muscle from RamKO mice compared to that from control littermates (*). It was previously 
shown that skeletal muscle specific mTORC1 inactivation reduces the content of glycogen 
phosphorylase, a result consistent with glycogen accumulation in RamKO muscle fibres [11, 
12]. Nevertheless, SDS gel electrophoresis of isolated SR membrane fractions revealed that 
the band with an apparent molecular mass of 97 kDa was enriched in the total SR of 
RamKO mice (Fig. 6A). Mass spectroscopy identified the 97 kDa sarcoplasmic reticulum 
protein band as the glycogen phosphorylase (GP). This finding was further confirmed by 
staining western blot of total SR membrane proteins with specific anti-glycogen 
phosphorylase antibodies (Fig. 6D). Quantification showed that ablation of raptor led to a 
2.9 fold increase of glycogen phosphorylase associated with the total SR membrane fraction  
(Fig. 6B). Subfractionation of SR membranes by sucrose density centrifugation revealed 
that glycogen phosphorylase was enriched in the light R1 fraction (Fig. 6C; white 
arrowheads), which is made up of membranes derived from longitudinal SR, sarcolemma 
and T tubules. Glycogen phosphorylase activity is regulated in several ways including (i) 
substrate availability, (ii) interconversion (phosphorylation/dephosphorylation) and (iii) 
allosteric modification, with AMP being a key activator [45, 46]. We assessed whether the 
cAMP-stimulated (GP-a) or cAMP non-stimulated (GP-b) forms of the enzyme are enriched 
in the muscle from RamKO mice; as shown in Figure 6E, there was a similar increase in 
GP-total and GP-b activity, suggesting that the cyclic AMP-non-stimulated form of 
glycogen phosphorylase is enriched in the SR membranes of RamKO mice [47].  Hirata et 
al. reported that GP is a negative regulator of RyR since it decreases mastoparan induced 
calcium release [48], and thus may affect the twitch kinetics. To explore this possibility, we 
studied Ca2+ homeostasis in enzymatically dissociated single EDL and soleus fibres.   
 
Calcium transients on isolated EDL and Soleus fibres 
 To assess the resting calcium concentration we loaded EDL and soleus fibres with 
the ratiometric fluorescent Ca2+ indicator Indo-1. In both WT and RamKO mice the resting 
[Ca2+] in EDL fibres from control mice is slightly higher compared to that in soleus fibres.  
On the other hand EDL and soleus fibres from RamKO mice exhibited a small but 
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significant decrease of the resting [Ca2+] compared to control littermates (Table 1). Mag-
Fluo-4 a low affinity calcium indicator was used to monitor rapid Ca2+ transients (Fig. 7) 
elicited by an action potential in single EDL and soleus fibres excited by supramaximal field 
stimulation [49]. The results we obtained are summarized in Table I. The ΔF/F peak Ca2+ 
transient amplitude in EDL from WT (0.46± 0.04, mean ±S.E.M. n=29 fibres) mice was 
18%  and 22% higher compared to that of  soleus muscles  from WT (0.38±0.02,  mean ± 
S.E.M. n= 22 fibres) and RamKO (0.36 ±0.02, mean ±S.E.M. n= 5 fibres) mice, 
respectively. Surprisingly, the peak amplitude and the 10-90% rise time of the calcium 
transients were not different between RamKO mice and control littermates both in EDL and 
soleus. The 10-90% fall time of the calcium transients in soleus from RamKO mice is 
increased compared to that of WT (120.2 ±15.7, n=25 vs 66.2±7.4, n=22 fibres, 
respectively; values are mean ±S.E.M.; p<0.05 Mann Whitney test). The 10-90% fall time 
of the calcium transients reflect the removal of calcium from the cytosol leading to muscle 
relaxation. Slow fibres are distinct from fast fibres since they typically display a lower 
relaxation rate compared to fast fibres [50].  In addition, peak calcium release induced by an 
action potential is lower in slow fibres compared to fast fibres [51]. The increase of 10-90% 
fall time and the decrease of ΔF/F peak Ca2+ transient are consistent with the observation 
that almost 100% of the fibres of the soleus from RamKO mice are of type 1 [12]. EDL 
fibres from RamKO mice exhibited a small and not- significant increase of 10-90% fall time 
of the calcium transients. Similar results were also obtained with enzymatically dissociated 
FDB fibres (not shown).  
The lack of a decrease of the peak amplitude calcium transients evoked by an action 
potential in RamKO EDL and soleus fibres is apparently inconsistent with the decrease of 
density of Cav1.1 in the T tubular membrane. A number of possibilities may account for this 
discrepancy. For example, the 50% decrease of Cav1.1 in RamKO fibres ought to be 
accompanied with a larger fraction of voltage-sensor uncoupled RyR1. It has been proposed 
that (i) the interaction of Cav1.1 with RyR1 inhibits the appearance of elementary calcium 
release events (ECRE) in mammalian adult muscle fibres [26, 50], and that (ii) the global 
calcium transients supporting EC coupling in skeletal muscle fibres may result from the 
summation of ECRE [30]. Equilibrium binding on total microsomes shows that in RamKO 
there are five/six uncoupled RyRs per voltage-sensor coupled RyR, while in WT there is 
one/two uncoupled RyR per voltage-sensor coupled RyR.  On the basis of the equilibrium 
ligand–binding data we reasoned that the doubling of the voltage-sensor uncoupled RyRs 
may affect ECRE.  If this were so, the release of calcium from voltage-coupled RyRs in 
RamKO fibres might propagate to adjacent voltage-sensor uncoupled RyRs triggering a 
larger number of ECRE, which together contribute to the global amplitude of the peak 
calcium transients in muscle fibres from RamKO.  In the next set of experiments, we set out 
to test this idea by measuring the ECRE properties in FDB fibres from WT and RamKO 
mice induced by hyperosmotic shock [26, 27], a treatment that weakness the inhibitory 
activity of Cav1.1 on the RyR1, and thus unmasks the spontaneous activity of RyR1.  
 
Elementary Calcium Release Events  (ECRE) in WT and RamKO FBD fibres 
Intact single FDB fibres from WT and RamKO mice were first perfused with normal Ringer 
solution,  and then they exposed to  hyperosmotic Ringer solution containing 50 mM CaCl2 
[26, 27]. After exposure to hyperosmotic solution the FDB fibres were rinsed with normal 
Ringer and their viability was confirmed by their ability to respond with a robust global 
calcium transient upon the delivery of an action potential by supramaximal field stimulation 
(Fig1S).  The perfusion of FDB fibres from WT and RamKO with normal Ringer solution 
did not cause the appearance of spontaneous elementary calcium release events (ECRE)( 
Fig. 8A, C,  D and F left panels).  Exposure to hyperosmotic Ringer solution solution 
containing 50 mM CaCl2 [26, 27], induced localised increase of Fluo-4 fluorescence signals, 
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which were mostly distributed under inner leaflet of the sarcolemma (Fig. 8 B and E, 
Supplementary videos).  Reperfusion of FDB fibres with normal Ringer abolished the 
appearance of local transient increases of Fluo-4 fluorescence (Fig. 8C and Fig.8F). Fig. 8H 
and Fig. 8I show x,t line scan images of fibre exposed to hyperosmotic solution.  As can be 
seen hyperosmotic treatment causes transient increase of the fluorescence, and on the basis 
of the criteria proposed by Kirsch et al. [30], we refer to the local increase of Fluo4 
fluorescence as elementary calcium release events (ECRE).  ECRE analysis was performed 
with Sparkmaster plug-in, and ECRE were divided into two groups: short lasting (sparks-
like) events having a FDHM lower than 50 ms and long lasting (ember-like) events FDHM 
higher than 50 ms [29]. Analysis of 1923 and 2547 short lasting ECRE from WT and 
RamKO fibres revealed significant differences of the morphological parameters of ECRE. 
Although the amplitude of short lasting ECRE was not different between WT and RamKO 
FDB fibres, the latter fibres exhibited a 10%  increase of  both FWHM   (0.89 ± 0.01 vs 
0.98± 0.01 µm  for WT and RamKO FDB fibres, respectively; P<0.05) and FDHM (13.31 ± 
0.26 vs 14.11±0.24 ms for WT and RamKO FDB fibres, respectively; P<0.05). The 
estimated ECRE mass at peak time of the ΔF/F was 37% increased in RamKO FDB fibres 
(0.62± 0.02 vs 0.85± 0.03 µm3 for WT and RamKO FDB fibres, respectively; P<0.05).  The 
increase of estimated ECRE mass was paralleled by a 30% increase of the frequency of 
short lasting ECRE events in RamKO fibre (6.81±0.36 vs 8.83±0.40 sparks/image for WT 
and RamKO FDB fibres, respectively; P<0.05).  The appearance of ECRE in both WT and 
RamKO fibres dropped to zero upon preincubation of the fibres with RyR, indicating that 
the calcium source flux of ECRE are the RyR calcium release channels (Fig. 8 J and Fig8 
K). 
 
  
 12 
DISCUSSION 
In this study we investigated the structural and functional properties of the 
membrane compartment involved in excitation-contraction coupling of skeletal muscle from 
WT and Raptor KO mice. Our results show that muscle specific ablation of Raptor and the 
consequent downregulation of the mTORC1 complex, causes a 1.70 fold increase of the 
RyR1 to dihydropyridine receptors ratio in total sarcotubular membranes.  This event 
increases both the frequency and width of elementary calcium release events (ECRE) 
induced by exposure of FDB fibres to hyperosmotic shock. In addition, in RamKO skeletal 
muscles, the cAMP non-stimulated form b of glycogen phosphorylase is mostly associated 
with the sarcotubular membrane fraction. We propose that mTORC1 signalling affects the 
structure and function of the membrane compartments involved in excitation-contraction 
and excitation-glycogen metabolism coupling. 
 
Cav1.1 content in RamKO mice  
The transmission of the signal from the T tubular membrane to the sarcopalsmic 
reticulum is performed by a supramolecular complex in the contact region between the two 
membrane systems. The core components of such a complex are the alpha1-subunit (Cav1.1) 
of the L-type Ca2+ channel dihydropyridine receptor (DHPR), the ryanodine receptor (RyR)  
and calsequestrin which serve as voltage sensor, SR Ca2+ release channel, and calcium 
storage protein, respectively [13]. The decrease of the membrane density of DHPR is not 
accompanied by a decrease of the membrane density of the RyR1 whereby the ryanodine to 
dihydropyridine receptors ratio of RamKO mice is higher compared to that of WT mice. 
The lower membrane density of the DHPR is not due to mis-localization of the protein to a 
different membrane compartment as the total amount of Cav1.1 was also reduced in the total 
muscle homogenate, nor due to decreased levels of specific transcript. A similar decrease of 
the membrane density of DHPR was previously reported by Avila and Dirksen [37] upon 
acute treatment of cultured myotubes with 20 µM rapamycin and confirmed in the present 
study in C2C12 cells treated in culture with rapamycin. However, it seems that the functional 
effect caused by the decreased membrane density of DHPR depends on the maturation stage 
of muscle cells, namely in myotubes  [37] it causes a substantial decrease of the voltage-
depenent calcium release, while in mature RamKO FDB fibres (this work) calcium release 
evoked by  action potential is not affected. The decrease in DHPR content may be caused by 
increased degradation via ubiquitination and indeed it has been shown that rapamycin 
treatment induces protein ubiquitination in rat myocardium and mTOR inhibition induces 
autophagy [53, 54]. Interestingly, the ratio of DHPR to RyR1 in slow fibers is lower 
compared to that in fast fibers, leading to a higher content of uncoupled RyR1 in soleus 
compared to fast twitch muscles [55]. Thus, our equilibrium binding results are consistent 
with the fast to slow fiber transition in RamKO muscles [12], in particular more than 90% of 
soleus’s fibres from RamKO are of type 1. Importantly however, while this reduction in 
voltage sensor does not seem to be directly responsible for changes in E-C coupling, it may 
trigger some of the structural variations seen on biopsied muscles, particularly the presence 
of smaller fibres containing core-like structures such as those described in the mouse 
RamKO muscles [12]. Indeed, immunofluorescence analysis of skeletal muscle biopsies 
from some patients with recessive RYR1 mutations show that mis-alignment of RyR1 and 
DHPR is a feature of some patients with core myopathies [56]. A decrease of the DHPR 
calcium channels has also been reported in myotubular/centronuclear myopathy [57, 58]. 
Razidlo et al. [59] proposed that the lack of myotubularin inhibits Akt signalling to 
mTORC1 leading to down-regulation of the signalling pathways mediated by the mTORC1 
complex. 
 
RyR/ Cav1.1 ratio in skeletal muscle of RamKO mice. 
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High resolution electron microscopy has demonstrated that Cav1.1 are organised in 
groups made up of four units regularly oriented in the T- tubular membrane to form 
structures referred to as tetrads, which correspond to the position of every other RyR 
localised in the opposite SR terminal cisternae membrane [14]. Equilibrium binding with 
total sarcotubular membrane fractions show a ryanodine to dihydropyridine receptor ratio of 
0.79 and 1.35  for WT and RamKO skeletal muscle, respectively.  The RyR/DHPR ratio we 
found in WT is consistent with that found by others in total rabbit skeletal muscle 
homogenates and total microsomal fraction [60-62]. Assuming that there are 4 PN200-110 
binding sites per tetrads and one ryanodine binding site per RyR, these results imply that in 
sarcotubular membranes from RamKO mice there is one tetrad-coupled RyR every 5/6 
RyRs, while in WT sarcotubular membranes there is one tetrad-coupled RyR every 2-3 
RyRs. The ryanodine to dihydropyridine receptor ratio of skeletal muscle from RamKO 
mice is more similar to that of cardiac  [60] and or amphibian skeletal muscles  [61] than 
that of mature mammalian skeletal muscle. Thus, at this time it is difficult to reconcile the 
functional behavior of such a large fraction of uncoupled RyR in RamKO fibers with that of 
uncoupled RyR presents in WT skeletal muscle having canonical ryanodine to 
dihydropyridine receptor ratios.  Although a great deal of data do not support the notion that 
in mammalian skeletal muscle fibers uncoupled-RyR are activated by the calcium released 
from voltage sensor coupled RyRs via calcium-induced calcium release [63-65], we can not 
exclude the possibility that the large “cardiac-like” fraction of voltage-sensor uncoupled 
RyR in RamKO fibers  might have distinct functional behavior.  
 
Global calcium signals and elementary calcium release events in WT and RamKO 
fibres. 
Measurements of global calcium in single EDL, soleus and FDB show no differences 
in the peak amplitude of depolarization-induced Ca2+ release between WT and RamKO. 
Such   a results was unexpected because of the significant decrease of the membrane density 
of DHPR, and is not consistent with the general idea that the DHPR drives the voltage-
dependent activation of RyR1. Nevertheless, it may be possible that the large fraction of 
uncoupled RyRs are sensitive to regulation by physiological modulators and the activation 
of the uncoupled RyRs might compensate for the lower content of voltage sensors in 
RamKO muscles. This line of reasoning is supported by our finding of the modification of 
the morphology of ECRE induced by osmotic shock, a maneuver which weakens the control 
of the DHPR over the RyR1, and may thus unmask a distinct regulatory mechanism of 
uncoupled RyR1 in RamKO fibres.  ECRE in RamKO fibres are spatially wider and this 
does apparently not correlate with the changes of the amplitude of ECRE between WT and 
RamKO fibres. A larger FWHM of ECRE  in  FDB fibre from raptor knock-out mice  may 
be caused by a decrease of the removal of calcium at the source site by SERCA and/or by 
cytosolic calcium binding proteins. A decrease of removal of calcium is likely not due to 
changes in the membrane density of the Ca2+ pump, since staining of western blots with 
either SERCA1 or SERCA2 Ab did not reveal differences in their protein level in crude SR 
membrane preparations. The wider ECRE in RamkO fibres may result from the recruitment 
of the larger fraction of  RyRs which are not directly coupled to DHPRs, as described in 
frog skeletal muscles [65], a tissue with  a ryanodine to dihydropyridine receptors ratio 
higher  than that of mammalian skeletal muscle fibres [61]. If such a distinct functional 
behaviour is also operating in RamKO skeletal muscle fibres under physiological condition, 
it is possible that during an action potential voltage-operated RyR1 channels open and the 
calcium released by the voltage-operated RyR1s propagate to neighbouring uncoupled 
RyR1 channels. The latter channels release calcium by calcium-induced calcium release 
mechanism and ultimately contribute to the calcium transient.  
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Compartmentalisation of glycogen phosphorylase to SR membrane  
In skeletal muscle glycogen forms a dense network of granules which are mostly 
localised on the myoplasmic surface of terminal cisternae and along the membrane of the 
fenestrated collar [66]. Excitation of skeletal muscle is associated by a rapid (seconds) 
glycogen breakdown via activation of glycogen phosphorylase, the enzyme responsible for 
the release of glucose-1-P from glycogen particles, which ultimately supports muscle 
metabolism during exercise.  It has been demonstrated that excitation–glycolysis coupling 
occurs without an increase of the myoplasmic concentration of cAMP and without the 
subsequent conversion of GP-b to GP-a by the cAMP-dependent activity of phosphorylase 
kinase [67]. GP-b can be allosterically activated by AMP, this cAMP-non stimulated 
activity is thought to be predominant during the early phases of skeletal muscle contraction  
[68]. In resting conditions, the intracellular concentration of AMP is not sufficient to 
activate GP-b, thus GP-b is thought to be inactive in resting muscles [69]. During strenuous 
muscle activity however, the intracellular AMP concentration increases, signalling a 
demand in energy requirement. AMP is the product of the activity myokinase, an enzyme 
which utilises as a substrate the ADP generated by the activity of the SR CaATPase, Na-K-
ATPase and myosin-ATPase. In resting conditions, the average myoplasmic concentration 
of AMP is 0.2 µM and it increases 10-fold during intense muscle activity [70, 71]. However, 
in regions of high ATP consumption such as in domains where the SERCA enzyme pumps 
calcium back into the SR, a greater amount ATP is required and this may be made available 
by the allosteric activation of GP-b by AMP. Interestingly, lower glycogen content and an 
increase in its degradation have been linked to a fast decay of calcium transients and force 
during tetanic stimulation [72, 73]. The cAMP dependent active form of GP-a inhibits the 
activation of the RyR1 by caffeine [48]. Thus, the presence of GP-b associated with the SR 
membrane is consistent with the concept that the increase in fatigue resistance described in 
RamKO [11] mice correlates with sustained calcium release thanks to the 
compartmentalisation to the SR of an energy supplying system made up of glycogen and 
GP-b. 
Overall these results indicate that the muscle phenotype of RamKO mice is complex 
and due to the interaction of multiple biochemical pathways governed by the 
mTORC1signaling complex. This study shows that an adequate mTORC1 activity is 
required to maintain the structure and the function of the membrane compartments involved 
in excitation-contraction coupling. 
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Table 1 
Kinetic properties of calcium transients of isolated EDL and soleus fibers from control 
and RamKO mice 
 
 Resting Ca2+  [nM] a 
Peak 
Amplitudeb 
∆F/F 
Time to 
peak (ms) 
 
Rise Time 
10-90% (ms) 
Fall Time 
10-90% (ms) 
EDL 
control  
141.0±0.35 
(n=23) 
0.46±0.04 
(n=29) 
2.9±0.1 
(n=29) 
1.7±0.05 
(n=29) 
34.1±4.3 
(n=29) 
EDL 
RAmKO  
115.5±4.8* 
(n=21) 
0.43±0.02 
(n=27) 
3±0.1 
(n=27) 
1.8±0.06 
(n=27) 
39.4±5.4 
(n=27) 
Soleus 
control  
117±3.6 
(n=26) 
0.38±0.02 
(n=22) 
3.4±0.2 
(n=22) 
2.1±0.2 
(n=22) 
66.2±7.4 
(n=22) 
Soleus 
RAmKO 
 
93.8±4.26* 
(n=8) 
0.36±0.02 
(n=25) 
3.4±0.1 
(n=25) 
2.1±0.1 
(n=25) 
 
120.3±15.7* 
(n=25) 
 
 
Values are mean+/-s.e.m., n= number of  fibres from 6 WT and RamKO mice 
 *P<0.05 Mann Whitney U test,  
a Calcium measurements performed with the ratiometric indicator indo-1; 
b Calcium measurements performed with Mag-Fluo-4; 
  
 22 
Table 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are expressed as mean ± s.e.m.. 
a:  WT 168 images,  RamKO 162 images 
b: number of ECREs analyzed in 25 fibres and 26 fibres  from  5 WT and  RamKO 5 mice, 
respctively. 
Morphology of ECREs in Skeletal muscle fibers  
 
Amplitude 
(ΔF/F0) 
FWHM  
(µm) 
FDHM  
(ms) Mass 
Freqa 
(Sparks/image) N
b
 
<50 ms 
ECREs 
WT 0.38±0.00 0.89±0.01 13.31±0.26 0.62±0.02 6.81±0.36 1923 
RamKO 0.38±0.00 0.98±0.01* 14.11±0.24* 0.85±0.03* 8.83±0.40* 2547 
 
>50 ms 
ECREs 
 
WT 
 
0.56±0.01 
 
1.32±0.02 
 
143.36±3.32 
 
2.51±0.17 
 
2.51±0.17 
 
538 
RamKO 0.60±0.01* 1.45±0.02* 138.49±2.80 3.56±0.18* 3.56±0.18* 731     
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Figure legends: 
Figure 1: Mechanical properties of isolated EDL and soleus muscles from RamKO and 
control littermates. Isolated muscles from 8 week-old mice were electrically stimulated as 
described in the Experimental Procedures section. Top panels show single twitches, bottom 
panels maximal tetanus force. Dotted line RamKO mice, continuous line control littermates. 
Note that the muscles from RamKO mice developed approximately 20% less force than 
controls. Slow twitch muscles also showed a significant decrease in the half relaxation time. 
Traces are representative of experiments carried out by Bentzinger et al. [12] on at least 3/4 
different muscle preparations.  
Figure 2: Biochemical characterization of SR proteins from RamKO mice. Left panels 
show representative Western blots with specified antibodies; right panels, mean band 
intensity (±SD) of 6-9 determinations from 3 different SR preparations. Values were 
normalized with respect to intensity values obtained from control littermates. White bars, 
controls; black bars, RamKO. **P<0.002. 
Figure 3: Cav1.1 is decreased in RamKO mice. A. Equilibrium binding of PN200-110 to 
skeletal muscle SR of control (filled circle) and RamKO (empty boxes) mice. Data points 
represent mean (± S.E.M.) of 6 determinations carried out in two different SR preparations. 
B. and C. Western blots of CaV 1.1 and CaV β1 in SR of control (empty bars) and RamKO 
mice (filled bars) and mean band  of 5-7 determinations from 3 different SR preparations.  
Figure 4: Cav1.1 decrease in RamKO mice is not due to a decrease in transcription of 
Cav1.1 mRNA. A. Semi-quantitative RT-PCR of Cav1.1. The figure represents results 
obtained in four different experiments with RNA extracted from two muscle preparations. B. 
Western blot of total muscle homogenate with anti-Cav1.1 and anti-albumin, a marker for 
transverse tubule content. The bar histogram shows mean (±S.E.M.) band intensity of 6 
determinations from 4 different muscle preparation; band intensity from the RamKO mice are 
normalized to that obtained in control littermates. C. The Cav1.1 promoter is not affected by 
treatment with 20 µM rapamycin as determined by luciferase activity. No activity was seen 
upon transfection of cells with a control plasmid (white bars) nor upon transfection of 
HEK293 with the luciferase reporter (black bars). C2C12 cells transfected with a control 
plasmid showed no luciferase activity, while transfection with the luciferase reporter resulted 
in strong activity which was not affected by 2 or 16 h incubation with rapamycin (black bars).  
D. Rapamycin treatment of C2C12 cells was effective as it resulted in the decrease of 
phosphorylation of S6 after 2 and 16 hours. E. Rapamycin treatment of differentiated C2C12 
causes a decrease in CaV1.1 as determined by Western blotting. Cells were treated with 20 
µM rapamycin for 16 hours and 25 µg of microsomes were loaded on a 7.5% SDS PAG and 
blotted onto nitrocellulose. Blot was probed with anti - CaV1.1, stripped and re-probed with 
anti-calreticulin Ab as a loading control. Asterisk indicates the band corresponding to the 
CaV1.1 protein. 
Figure 5: Ryanodine receptor content and functional characteristics are not changed in 
RamKO mice. Left panel- Representative Western blot of total SR and mean band intensities 
(±SD) of 8 determinations from 3 different SR preparations. Top Right-[3H]Ryanodine 
binding to SR preparations from control (filled circles) and RamKO (open boxes) mice were 
performed as described in the Experimental Procedures. Data points represent the mean 
(±S.E.M.) of 12 determinations from 3 different SR preparations. No significant change in 
the Bmax or apparent KD was found. Bottom Right- Ca2+ dependent [3H]Ryanodine binding to 
SR preparations from control (filled circles) and RamKO (open boxes) mice. Data points 
represent mean (±S.E.M.) of 6 determinations on 2 different SR preparations. 
Figure 6: Glycogen Phosphorylase (GP) is accumulated in the SR of RamKO mice and 
represents mainly the enzymatically inactive form. (A) Ten µg of protein from total 
skeletal muscle homogenate, myoplasm or SR fraction was separated on a 7.5% SDS-PAGE 
and stained with SimplyBlue Safe Stain. (B) Densitometric analysis of GP band in total SR of 
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control (white bars) and RamKO (black bar) mice. (C) SR was fractioned into light SR (R1), 
longitudinal SR (R2) and terminal cisternae (R4). Fifteen µg of protein from each fraction 
was loaded on a 7.5%  SDS-PAGE and stained with SimplyBlue Safe Stain or (D) blotted 
onto nitrocellulose and stained with anti-glycogen phosphorylase Abs. White arrows in C 
indicate glycogen phosphorylase, which is enriched in the light SR fraction R1. (E) Total (left 
bar histogram) and inactive form (right bar histogram) glycogen phosphorylase enzymatic 
activity in SR from control (white bars) and RamKO (black bars) mice. Values represent the 
mean (± S.D.) of 11 determinations from 3 different SR preparations. *** P<0.05 
Figure 7: Changes in the myoplasmic [Ca2+] of individual, chemically dissected EDL 
and soleus fibres. Control and RamKO fibres were loaded with 10 µM Mag-Fluo-4AM in 
Tyrode's Solution for 10-15 minutes at 20°C. This solution was replaced and acquisitions 
were made during continuous perfusion with Tyrode’s buffer plus 50 µM BTS. Calcium 
transients were elicited by single pulses of 1 ms duration, through a platinum electrode inside 
a glass pipette placed near the fibre surface. The representative traces from EDL (panel A) 
and soleus (panel B) show no differences in the peaks and velocities of the Ca2+ transients; 
there is a significant increase in the half relaxation time in soleus fibres from RamKO mice. 
See Table I for a thorough analysis of the kinetic parameters. 
Figure 8: Osmotic-shock triggered ECRE are more frequent in FBD fibres from 
RamKO than WT mice.  ECREs were triggered by exposure of FDB fibres to a 
hyperosmotic solution.  Panels A-F: left images show Fluo4 fluorescence and right images 
brightfield images of the same FDB fibre. Scale bar = 30 µm. Panels A and D show (xy) 
images of the calcium fluorescence (AU) in WT and RamKO fibres in Normal Ringer, panels 
B and E show images of the same fibres after hyperosmotic shock treatment and C and F 
show images of the fibres after 10 min re-perfusion with a normo-osmotic Ringer solution; as 
shown after removal of the hyperosmotic medium ECRE are no longer visible. Panels H and 
I are pseudocoloured linescan images (xt) showing in detail the ECREs shape in WT an 
RamKO fibres when bathed with hypertonic solution. Panels J and K show that ECREs are 
due to the openining of RyRs as they are abolished by a 30 min pre- incubation with 10 µM. 
Scale bar panels H-K: Horizontal: 100 ms, Vertical: 10 µm. 
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15. Supplementary figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 1. Global Ca2+ transients in mouse FDB fibers isolated from WT and 
RamKO littermates elicited before and after hyperosmotic stress-induced-ECREs. FDB fibers 
were loaded with Fluo4 and electrically stimulated to check their viability before, during and 
after application of the hypertonic solution. Panels A and D display representative traces of 
Ca2+ transient triggered by an electrical pulse (4ms, 30-40 V) in WT (panel A) and RamKO 
(panel B) fibers respectively. Cells lose the ability to contract after a 10 min exposure to the 
hyperosmotic solution (B, E). Panels C and F show that the Ca2+ transients recover after 10 
min of washing with NR (290 mOsm). 
 
